Close Menu

NEW YORK (GenomeWeb News) – The 5-year, €12 million ($15.9 million) 4DCellFate project kicked off today aimed at investigating how the polycomb repressive complex (PRC) and nucleosome remodeling and histone deacetylase (NuRD) complexes function across the genome and time during differentiation.

The EU-funded project will apply technologies such as proteomics, high-throughput screening, structural biology, microscopy, and computational modeling to translate basic research findings into new research and medical solutions, CLC Bio, one of the partners in the project said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.